Login to Your Account

Genentech, Biogen Idec Gain Approval Of Rituxan In RA

By Aaron Lorenzo

Thursday, March 2, 2006
The FDA approved Rituxan (rituximab) for rheumatoid arthritis, broadening the therapeutic antibody’s label and potentially its revenue. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription